Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Fostemsavir in Hepatic Impairment
NCT02467335Phase 1Completed
- Sponsor
- ViiV Healthcare
- Start
- Jan 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of fostemsavir in human immunodeficiency virus infection (HIV) (4 arms), sponsored by ViiV Healthcare. Primary endpoints: Peak Plasma Concentration at 5 days, Area Under the Curve to Infinity at 5 days and 1 more. Started Jan 2015; status: completed.
02
Drugs
fostemsavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02467335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02467335.